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ABSTRACT 
Here, we report on the prevalence of allergic conjunctivitis and positive skin prick test (SPT) results in 
relation to respiratory allergic conditions among patients with symptoms of allergies at a respiratory 
outpatient clinic. A questionnaire survey of symptoms (i.e., asthma-like, rhinitis, and conjunctivitis 
symptoms) involving 1522 patients was carried out. The responses of 1242 patients indicated that they had 
allergic conjunctivitis, asthma, rhinitis, or a combination of these conditions, and 869 of these patients 
underwent SPTs that assessed responses to 40 allergens. 
Allergic conjunctivitis was found to be very common (40%, 497 out of 1242 patients) among those with 
symptoms of allergies. Conjunctivitis was slightly more common among women, while rhinitis was more 
common among men. Patients with both conjunctivitis and rhinitis were more likely to undergo SPTs, and 
they had a higher rate of positive SPTs. The coexistence of two or more comorbidities increased the risk of 
having an immunoglobulin E (IgE)-mediated allergy (based on the SPT results) compared to having each of 
the conditions alone. In conclusion, allergic conjunctivitis can occur either alone or with asthma and/or 
rhinitis. It is not always accompanied by rhinitis, but the coexistence of these conditions was the strongest 
indicator of IgE-mediated allergies. 
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INTRODUCTION 
In the past decade, guidelines regarding the 
management of asthma (1) and allergic rhinitis (2) have 
been published separately. However, the “one airway, 
one disease” idea and the similar mechanisms of allergic 
inflammation that exists between asthma and allergic 
rhinitis resulted in the creation of a new set of guidelines 
concerning both comorbidities. These guidelines were 
prepared by an initiative called Allergic Rhinitis and its 
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Impact on Asthma (ARIA), which works with the World 
Health Organization. Nevertheless, these guidelines do 
not include allergic conjunctivitis as an allergic 
comorbidity. Allergic conjunctivitis with allergic rhinitis is 
often referred to as “allergic rhino-conjunctivitis” 
because of the extremely frequent coexistence of these 
conditions. Moreover, multicenter studies such as the 
International Study of Asthma and Allergies in Childhood 
(ISAAC) (3,4) and the National Health And Nutrition 
Examination Survey (NHANES) (5) refer to concurrent 
allergic conditions of the nose and eyes as “allergic rhino-
conjunctivitis.” The term “hay fever” is also commonly 
used, and it refers to a group of symptoms that occur in 
sensitized individuals due to seasonal pollen exposure, 
such as sneezing and nasal itchiness, discharge, and 
congestion, which can be accompanied by allergic ocular 
symptoms. 
The extent to which allergic conjunctivitis is a part of the 
“asthma–allergic rhinitis” entity has not been evaluated 
rigorously and, consequently, this issue has not been 
sufficiently addressed by the relevant guidelines.  
The eyes are rarely the only organs that exhibit 
immediate allergic-type responses (almost 10% of 
patients with allergies have solely ocular symptoms). 
Often, patients with ocular allergies have coexisting 
atopic manifestations such as rhinitis, asthma, urticaria, 
or eczema. Despite this, ocular signs and symptoms can 
sometimes be the first and most obvious feature of a 
broader allergic response that prompts patients to visit 
their physicians (6).  
It is estimated that, in the USA, allergies involving the 
eyes, nose, and throat affect 18.3% of the general 
population (7). Moreover, a study in Sweden reported 
that the prevalence of allergic conjunctivitis was 19% 
among 12–13-year-old schoolchildren, with 92% of those 
with allergic conjunctivitis having allergic rhinitis (8). In 
general practice, about 6% of consultations are for 
inflamed or red eyes, 35% of which are caused by 
allergies, according to a survey of ophthalmologists and 
general practitioners in nine countries in Eastern Europe 
and the Middle East (9). Ocular allergies account for 10% 
of the ophthalmology outpatient visits in the Asia Pacific 
region, and although red eye is a very uncommon 
primary symptom for allergists, it commonly 
accompanies other allergy symptoms, occurring in 
around 25% of allergists’ patients (10). Among patients 
with seasonal and perennial allergic conjunctivitis, ocular 
allergy symptoms are twice as common as nasal 
symptoms alone (11). 
Taking into consideration all the above, it could easily be 
concluded that the prevalence of ocular allergies is 
underestimated and, hence, that ocular allergies are 
underdiagnosed and undertreated. This study is a 
continuation of a study that we published in 2013, which 
evaluated the prevalence of conjunctivitis and the most 
common allergens in Northern Greece (6). The objective 
of the present study was to retrospectively evaluate the 
prevalence of allergic conjunctivitis and positive skin 
prick test (SPT) results in relation to allergic respiratory 
conditions among patients with symptoms of allergies at 
a respiratory outpatient clinic. In addition, we 
determined the gender distribution in groups of patients 
categorized according to their symptoms (i.e., asthma-
like symptoms, rhinitis, and conjunctivitis). Moreover, we 
determined which combination of conditions was the 
strongest indicator of immunoglobulin E (IgE)-mediated 
allergies (as indicated by positive SPTs).  
Our objective was to encourage ophthalmologists, 
allergists, pulmonologists, and general practitioners to 
recognize conjunctivitis as a frequent comorbidity in 
patients with allergies. 
 
METHODS 
This study is a retrospective study that involved analyzing 
data from the electronic archives of an outpatient 
respiratory clinic in Northern Greece. None of the 
personal information was identifiable and no invasive 
procedures were conducted. The study was approved by 
the Ethics Committee of the Aristotle University of 
Thessaloniki, Greece. 
The study was based on 10,000 patients with respiratory 
symptoms who had been referred during a 14-year 
period (1996–2010). Of these patients, 1522 who were 
suspected of having an allergic condition (such as 
asthma, rhinitis, or conjunctivitis, based on their clinical 
history and an examination) filled in a questionnaire that 
was designed for the evaluation of allergic symptoms and 
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the subsequent diagnosis of allergic conditions. The 
questionnaire contains 200 questions and is used by the 
Pulmonary Department of the Aristotle University of 
Thessaloniki. It enables the collection of information on 
personal characteristics (such as age and profession), 
symptoms of the upper and lower respiratory systems 
and the eye (i.e., wheezing, dyspnea, cough, sputum, 
rhinorrhea, sneezing, and runny, itchy, and red eyes), and 
the time of year and time of the day during which these 
symptoms appear. There are also questions concerning 
symptoms caused by a variety of allergens (i.e., dust, 
pets, particular foods, drugs, cold air, and exercise) as 
well as the patient’s medical history and previous and 
current medication use. The screening question on 
asthma-like symptoms, rhinitis, and conjunctivitis was as 
follows: Do you have or have you had (during last year) 
any of the following symptoms: (A) dyspnea, wheezing, 
noisy breathing, or asthma; (B) a runny nose or allergic 
sneezing; and (C) watery, itchy, or red eyes? 
Based on their responses, the patients were categorized 
into seven groups, as follows: 
 
Group A: Patients with asthma only [A – R – C] 
Group B: Patients with rhinitis only [R – A – C] 
Group C: Patients with conjunctivitis only [C – A – R] 
Group D: Patients with asthma and rhinitis but not 
conjunctivitis [A + R – C] 
Group E: Patients with asthma and conjunctivitis but not 
rhinitis [A + C – R] 
Group F: Patients with rhinitis and conjunctivitis but not 
asthma [R + C – A] 
Group G: Patients with all three conditions [A + R + C] 
 
 
Figure 1. Number of patients who completed the 
questionnaires and gender distribution by allergy-related 
symptoms. (M: men, W: women, A: asthma, R: rhinitis, C: 
conjunctivitis). 
 
 
The patients completed the questionnaires with the help 
of an experienced nurse. Subsequently, SPTs were 
recommended to all the patients and performed (by the 
same experienced doctor) after obtaining consent, as 
recommended by the European Academy of Allergology 
and Clinical Immunology (12) and the US Joint Council of 
Allergy Asthma and Immunology (13,14). It is important 
to note that undergoing an SPT was associated with a 
patient fee. Only 70% (869 out of 1242) of the patients 
consented to undergo SPTs. In our earlier study (6), 
positive reactions to any of the eight main allergens 
(cypress, Parietaria officinalis, European olive, dust mite 
mix, Alternaria spp., pet dander [dog and cat], and grass 
mix) were analyzed by patient group. The patients who 
underwent the SPTs had not been on any oral 
antihistamine and/or cortisone medications for at least a 
week prior to the SPTs. 
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The statistical analysis carried out using Statistical 
Package for the Social Sciences (SPSS) version 12 (SPSS 
Inc., Chicago, IL, USA). Chi-square tests used to 
determine whether the gender-related differences in the 
proportions of patients in each patient group were 
statistically significant. These tests also used to 
determine whether the gender-related and patient 
group-related differences in the proportions of patients 
who underwent SPTs and had positive SPTs results were 
significant. P values <0.05 were considered statistically 
significant. 
 
RESULTS 
Of the 1522 patients (636 men and 883 women) who 
completed the questionnaire, 280 reported that they had 
not experienced any of the assessed symptoms, so only 
the remaining 1242 (521 men and 721 women) were 
categorized into the patient groups described in the 
previous section. 
Out of the 1242 patients with allergies, 497 (40%) were 
assessed as having conjunctivitis. There were more 
women with conjunctivitis than men (311 women and 
186 men) (Figure 1). Among the patients with both 
asthma and conjunctivitis (group E), there were 
significantly more women than men (p=0.018). In 
addition, among the patients with conjunctivitis only 
(group C), there was a non-significant predominance of 
women (p=0.367), and among those with all three 
comorbidities (group G), there was also a non-significant 
preponderance of women (p=0.086). Men were 
significantly more common than women only among the 
patients with rhinitis only (group B) (p=0.002). 
Men underwent SPTs more often than women (75% vs. 
67%), with a significant difference between the genders 
in all patient groups (p=0.003). The patients who had 
conjunctivitis only (group C) and those who had rhinitis 
and conjunctivitis but not asthma (group F) underwent 
SPTs at significantly higher rates than those in all the 
other patient groups (p=0.005 and p=0.001, 
respectively). As shown in Table 1, around 70% of all the 
patients who underwent SPTs were positive for at least 
one of the 40 allergens tested. The patients who had 
rhinitis and conjunctivitis (group F) and those who had all 
three comorbidities (group G) had significantly higher 
rates of positive SPTs compared to those in all the other 
patient groups (p=0.005 and p=0.001, respectively). With 
respect to gender distribution, for men, groups C, E, F 
and G (conjunctivitis alone or accompanied by other(s) 
comorbidities), had higher proportions of positive SPTs. 
Men were more likely to undergo SPTs than women in all  
groups (p=0.003) as well as had higher proportions of 
positive SPTs in all the patient groups compared to 
women (p=0.003).  
 
Table 1. Frequency of patients with positive or negative SPTs 
among all the patients with allergy-related symptoms (SPT: skin 
prick test). 
 
 
DISCUSSION 
As the study related conjunctivitis to respiratory allergies, 
it was rather surprising to note that 49 out of the 1242 
patients who reported having allergic symptoms had 
conjunctivitis only (group C). This could be attributable to 
the patients’ perception that, for a minor case of 
conjunctivitis that is likely to be due to an allergy, the 
major problem could originate in the respiratory tract. A 
high percentage of patients (100% of the men and 75% of 
the women) with conjunctivitis only (group C) decided to 
Allergic 
sympto
ms  
groups 
Total 
No. 
Performed SPTs 
No/percentage 
(%) 
Positive SPTs 
No/percentage 
(%) 
Negative SPTs 
No/Percentage 
(%) 
A 401 242 (60.35%) 149 (61.57%) 93 (38.43%) 
B 129 97 (75.19%) 65 (67.01%) 32 (32.99%) 
C 49 41 (83.67%) 23 (56.10%) 18 (43.90%) 
D 215 160 (74.42%) 108 (67.50%) 52 (32.50%) 
E 102 60 (58.82%)  43 (71.67%) 17 (28.33%) 
F 117  98 (83.76%) 81 (82.65%) 17 (17.35%) 
G 229  171 (74.67%) 137 (80.12%) 34 (19.88%) 
Total 1242 869 (69.97%) 606 (69.74%) 263 (30.26%) 
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proceed with the SPTs. These patients, along with those 
with rhinitis and conjunctivitis (group F) underwent SPTs 
at significantly higher rates than those in all the other 
patient groups (Group C, p=0.005; Group F, p=0.001). 
This may have occurred because these patients had 
particularly troublesome symptoms or the symptoms 
may have been more strongly indicative an allergy. The 
fact that 65% of the men and only 50% of the women 
had positive SPTs (in Group C) shows that the men may 
have had a better perception of their condition and/or 
that, in some cases the women’s ocular symptoms may 
have been related to mechanical irritation caused by the 
use of cosmetics. 
Another important observation is that the proportion of 
patients with rhinitis and conjunctivitis (group F) who 
underwent SPTs (84%) was higher than those in the other 
patient groups, and these patients also had a higher rate 
of positive SPTs (83%) compared to those in the other 
groups. The percentages were also higher for the 
patients who had all three comorbidities (group G), at 
75% and 80%, respectively, but the differences were not 
significant (p=0.98).  
The patient group with the third highest rate of positive 
SPTs was the patients with conjunctivitis and asthma 
without rhinitis (group E). The results indicate that when 
conjunctivitis coexists with asthma without rhinitis 
(group E), there appears to be a stronger indication of 
IgE-mediated allergy than when asthma coexists with 
rhinitis without conjunctivitis (group D), especially in 
men. For men, the coexistence of conjunctivitis with 
either of the other conditions accompanied by a higher 
probability of IgE-mediated allergy. The presence of 
asthma alone or conjunctivitis alone (groups A and C, 
respectively) had the poorest prognostic value for 
positive SPTs for both men and women. 
The very high proportions of patients with both rhinitis 
and conjunctivitis (group F) and those with all three 
comorbidities (group G) who underwent SPTs indicates 
that the patients’ perception that there was an allergic 
background to their disease was stronger in groups F and 
G compared to among those with every other 
combination of comorbidities investigated. 
In addition, men were significantly more likely to 
undergo SPTs than women in all the patient groups 
(p=0.003). This may be attributable to socioeconomic 
factors, given that each patient incurred a fee when they 
underwent the SPT. As a result, only 70% of the patients 
(75% of the men and 67% of the women) underwent 
SPTs (despite the fact that the doctor recommended to 
each of them that they undergo the SPT). Lastly, men had 
considerably and statistically significantly higher 
proportions of positive SPTs in all the patient groups 
compared to women (p=0.003).  
There are no data concerning the prevalence of allergic 
conjunctivitis in adults with asthma in previous studies 
such as the ARIA review (3,15). Besides our previous 
study (6), the only studies about allergic conjunctivitis 
alone were conducted in pediatric populations (16-18) 
except for one, which involved young Italian men (19). As 
a result, it is difficult to estimate the proportion of 
individuals who have both rhinitis and conjunctivitis. This 
is likely to be because conjunctivitis symptoms are rarely 
considered to be a major issue, and they are presumably 
not spontaneously reported by patients with rhinitis 
and/or asthma in medical consultations or in 
questionnaire-based epidemiologic studies such as the 
ISAAC (4) or the European Community Respiratory Health 
Survey (ECRHS) (5). In keeping with the above 
hypothesis, the ARIA review (3) highlighted that the 
association between rhinitis and conjunctivitis maybe 
underestimated in epidemiologic studies and, 
presumably, the same is true for asthma and 
conjunctivitis. 
In daily clinical practice, diagnostic and therapeutic 
procedures generally focus on the most predominant 
condition. Hence, doctors usually neglect to ask patients 
about symptoms concerning organs that are not involved 
in the predominant condition (such as the eyes). This 
occurs despite the evidence that atopic conditions 
frequently occur together. Consequently, nose, lung, 
skin, and eye specialists often fail to treat patients 
holistically and, instead, treat only the system they 
specialize in. Our study clearly indicates that patients 
with respiratory symptoms usually have conjunctivitis, 
and among these patients, there is a greater proportion 
with positive SPTs (compared to those in other the 
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patient groups). More studies on whether patients with 
conjunctivitis symptoms as their main allergy symptoms 
also have a high risk of other allergic conditions are 
required. 
A potential limitation of the study is that it did not 
involve a sample from the general population, and 
instead focused on patients who were referred to an 
outpatient respiratory clinic (not to an allergist or an 
ophthalmologist). Furthermore, the screening questions 
referred to general asthma-like symptoms. Another 
consideration is that the questionnaire had a question on 
having watery, itchy, or red eyes and a separate question 
on rhinitis symptoms. As explained earlier in the 
Discussion, other studies have dealt with the symptoms 
of itchy and watery eyes and the symptoms of rhinitis 
together, as rhino-conjunctivitis. Finally, it is possible that 
some of the ocular symptoms could have been related to 
other causes of red eyes. 
In conclusion, conjunctivitis is a very frequent 
comorbidity among patients with respiratory and allergy 
symptoms. Conjunctivitis can occur without other 
symptoms of allergies, and coexistence with rhinitis is 
certainly not a prerequisite. Conjunctivitis is a separate 
entity from rhinitis, and, according to our study, their 
coexistence appears to be less common than is indicated 
in previous studies, in which the term “rhino-
conjunctivitis” has often been used (4,5). On the other 
hand, our results show that the coexistence of two or 
more potentially allergic comorbidities is associated with 
an increased probability of having positive SPTs 
(indicating IgE-mediated allergies) compared to each 
condition alone. 
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